Insmed Stock Today
| INSM Stock | USD 25.25 0.51 1.98% |
|
|
Insmed is selling at 25.25 as of the 30th of September 2023; that is -1.98% down since the beginning of the trading day. The stock's lowest day price was 25.13. Insmed has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Insmed Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of October 2021 and ending today, the 30th of September 2023. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of June 2000 | Category Healthcare | Classification Health Care |
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 143.8 M outstanding shares of which 13.68 M shares are currently shorted by private and institutional investors with about 8.33 trading days to cover. More on Insmed Inc
Moving against Insmed Stock
| - | 0.86 | DH | Definitive Healthcare | Report 2nd of November 2023 | PairCorr | |
| - | 0.8 | PFE | Pfizer Inc | Aggressive Push | PairCorr | |
| - | 0.79 | TFX | Teleflex Incorporated | Report 26th of October 2023 | PairCorr | |
| - | 0.78 | MCD | McDonalds | Report 30th of October 2023 | PairCorr | |
| - | 0.78 | HPQ | HP Inc | Fiscal Quarter End 31st of October 2023 | PairCorr | |
| - | 0.77 | KO | Coca-Cola | Report 24th of October 2023 | PairCorr | |
| - | 0.74 | CPA | Copa Holdings SA | Report 15th of November 2023 | PairCorr |
Follow Valuation Options Daily Balance Of Power
Report 26th of October 2023
Insmed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Insmed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Insmed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | William Lewis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Insmed report their recommendations after researching Insmed's financial statements, talking to executives and customers, or listening in on Insmed's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Insmed Inc. The Insmed consensus assessment is calculated by taking the average forecast from all of the analysts covering Insmed. Strong Buy11 Opinions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Piotroski F Score Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Insmed Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Insmed Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks. FrailDetails
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Insmed's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details Strong BuyUndervalued | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Insmed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Insmed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Insmed's financial leverage. It provides some insight into what part of Insmed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insmed Inc (INSM) is traded on NASDAQ Exchange in USA. It is located in 700 US Highway 202/206, Bridgewater, NJ, United States, 08807 and employs 736 people. Insmed is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Insmed's market, we take the total number of its shares issued and multiply it by Insmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Insmed Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 143.8 M outstanding shares of which 13.68 M shares are currently shorted by private and institutional investors with about 8.33 trading days to cover.
Insmed Inc currently holds about 554.87 M in cash with (400.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62.
Check Insmed Probability Of Bankruptcy
OwnershipInsmed secures a total of 143.8 Million outstanding shares. The majority of Insmed Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insmed to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insmed Inc. Please pay attention to any change in the institutional holdings of Insmed Inc as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Ownership Allocation
Check Insmed Ownership DetailsInsmed Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Insmed jumping above the current price in 90 days from now is about 14.16%. The Insmed Inc probability density function shows the probability of Insmed stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Insmed has a beta of 0.1326. This usually indicates as returns on the market go up, Insmed average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Insmed Inc will be expected to be much smaller as well. Additionally, the company has an alpha of 0.371, implying that it can generate a 0.37 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Insmed to move above the current price in 90 days from now is about 14.16 (This Insmed Inc probability density function shows the probability of Insmed Stock to fall within a particular range of prices over 90 days) .
Insmed Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Insmed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Insmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Insmed's value.| Instituion | Last Transaction | Type | Shares | Value | |
| Absolute Investment Advisers Llc | 2023-06-30 | Debt | 8.5 M | 7.1 B | |
| Vanguard Group Inc | 2023-06-30 | Common Shares | 13.3 M | 281.1 M | |
| Blackrock Inc | 2023-06-30 | Common Shares | 10.3 M | 216.4 M | |
| Price T Rowe Associates Inc | 2023-06-30 | Common Shares | 10.2 M | 214.6 M | |
| T Rowe Price Investment Management Inc | 2023-06-30 | Common Shares | 8.3 M | 175.2 M | |
| Deep Track Capital Lp | 2023-06-30 | Common Shares | 6.5 M | 137.2 M | |
| State Street Corp | 2023-06-30 | Common Shares | 6 M | 127 M | |
| Palo Alto Investors Lp | 2023-06-30 | Common Shares | 5.9 M | 124.3 M | |
| Macquarie Group Ltd | 2023-06-30 | Common Shares | 4.4 M | 92.7 M | |
| William Blair Investment Management Llc | 2023-06-30 | Common Shares | 4.3 M | 90.4 M | |
| Fmr Llc | 2023-06-30 | Common Shares | 4.1 M | 86.2 M |
Insmed Historical Income Statement
Insmed Inc Income Statement is one of the three primary financial statements used for reporting Insmed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Insmed Inc revenue and expense. Insmed Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Insmed Direct Expenses is very stable at the moment as compared to the past year. Insmed reported last year Direct Expenses of 55.13 Million. As of 30th of September 2023, Operating Expenses is likely to grow to about 698.7 M, while Cost of Revenue is likely to drop about 48.2 M. View More FundamentalsInsmed Stock Against Markets
Picking the right benchmark for Insmed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Insmed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Insmed is critical whether you are bullish or bearish towards Insmed Inc at a given time. Please also check how Insmed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Insmed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Insmed Corporate Directors
Insmed corporate directors refer to members of an Insmed board of directors. The board of directors generally takes responsibility for the Insmed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Insmed's board members must vote for the resolution. The Insmed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Randy Whitcomb | Lead Independent Director | Profile | |
| Steinar Engelsen | Independent Director | Profile | |
| Myrtle Potter | Director | Profile | |
| Leo Lee | Director | Profile |
How to buy Insmed Stock?
Before investing in Insmed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Insmed. To buy Insmed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Insmed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Insmed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Insmed Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Insmed Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Insmed Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Insmed Stock please use our How to Invest in Insmed guide.
Already Invested in Insmed Inc?
The danger of trading Insmed Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Insmed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Insmed. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Insmed Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in non-hispanic. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fund Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.26) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.184 | Return On Assets (0.33) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.